A248, a novel synthetic HDAC inhibitor, induces apoptosis through the inhibition of specificity protein 1 and its downstream proteins in human prostate cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Eun-Sun | - |
dc.contributor.author | Han, Gyoonhee | - |
dc.contributor.author | Park, Song-Kyu | - |
dc.contributor.author | Lee, Kiho | - |
dc.contributor.author | Kim, Hyun-Jung | - |
dc.contributor.author | Cho, Sung-Dae | - |
dc.contributor.author | Kim, Hwan Mook | - |
dc.date.accessioned | 2021-09-06T00:09:22Z | - |
dc.date.available | 2021-09-06T00:09:22Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2013-07 | - |
dc.identifier.issn | 1791-2997 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/102811 | - |
dc.description.abstract | Histone deacetylase (HDAC) inhibitors are emerging as potent anticancer agents due to their ability to induce apoptosis in various cancer cells, including prostate cancer cells. In the present study, we synthesized a novel HDAC inhibitor, A248, and investigated its apoptotic activity and molecular target in the DU145 and PC3 human prostate cancer cell lines. A248 inhibited the growth of DU145 and PC3 cells and induced apoptosis, as demonstrated by nuclear fragmentation and the accumulation of cells at subG1 phase of cell cycle. The treatment of DU145 and PC3 prostate cancer cells with A248 resulted in the downregulation of specificity protein 1 (Sp1) expression. Since the expression levels of survivin and Mcl-1 depend on Spl, we also investigated the effects of A248 on survivin and Mcl-1 expression using western blot analysis and immunocytochemistry. The results showed that A248 markedly decreased the expression of survivin and Mcl-1. These data suggest that A248 has apoptotic activity in human prostate cancer cells and that Spl may be the molecular target of A248 treatment for inducing apoptosis in prostate cancer cells. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPANDIDOS PUBL LTD | - |
dc.subject | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject | TRANSCRIPTION FACTOR SP1 | - |
dc.subject | GENE-EXPRESSION | - |
dc.subject | DNA-BINDING | - |
dc.subject | DOWN-REGULATION | - |
dc.subject | UP-REGULATION | - |
dc.subject | ACID | - |
dc.subject | SUPPRESSES | - |
dc.subject | SURVIVIN | - |
dc.subject | MECHANISM | - |
dc.title | A248, a novel synthetic HDAC inhibitor, induces apoptosis through the inhibition of specificity protein 1 and its downstream proteins in human prostate cancer cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Song-Kyu | - |
dc.contributor.affiliatedAuthor | Lee, Kiho | - |
dc.identifier.doi | 10.3892/mmr.2013.1481 | - |
dc.identifier.scopusid | 2-s2.0-84878933881 | - |
dc.identifier.wosid | 000321079300031 | - |
dc.identifier.bibliographicCitation | MOLECULAR MEDICINE REPORTS, v.8, no.1, pp.195 - 200 | - |
dc.relation.isPartOf | MOLECULAR MEDICINE REPORTS | - |
dc.citation.title | MOLECULAR MEDICINE REPORTS | - |
dc.citation.volume | 8 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 195 | - |
dc.citation.endPage | 200 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject.keywordPlus | TRANSCRIPTION FACTOR SP1 | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | DNA-BINDING | - |
dc.subject.keywordPlus | DOWN-REGULATION | - |
dc.subject.keywordPlus | UP-REGULATION | - |
dc.subject.keywordPlus | ACID | - |
dc.subject.keywordPlus | SUPPRESSES | - |
dc.subject.keywordPlus | SURVIVIN | - |
dc.subject.keywordPlus | MECHANISM | - |
dc.subject.keywordAuthor | A248 | - |
dc.subject.keywordAuthor | histone deacetylase inhibitor | - |
dc.subject.keywordAuthor | prostate cancer | - |
dc.subject.keywordAuthor | specificity protein 1 | - |
dc.subject.keywordAuthor | survivin | - |
dc.subject.keywordAuthor | Mcl-1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.